Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
22.22
+0.22 (1.00%)
Jan 2, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 2, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 117 | 5 | 31 | 40 | 70 | 173 | |
| Market Cap Growth | 170.35% | -83.48% | -24.23% | -42.33% | -59.48% | - | |
| Enterprise Value | 114 | -3 | 16 | 18 | 52 | 169 | |
| Last Close Price | 22.00 | 1.70 | 11.85 | 16.05 | 30.60 | 83.00 | |
| PB Ratio | 15.68 | 0.91 | 3.03 | 2.13 | 4.47 | 13.70 | |
| P/TBV Ratio | 4.80 | 0.91 | 3.03 | 2.13 | 4.47 | 13.70 | |
| Debt / Equity Ratio | - | - | 0.00 | - | - | - | |
| Quick Ratio | 5.36 | 4.13 | 4.19 | 12.85 | 14.22 | 18.25 | |
| Current Ratio | 5.41 | 4.17 | 4.21 | 12.98 | 14.28 | 18.27 | |
| Return on Equity (ROE) | -112.04% | -107.19% | -72.44% | -52.57% | -44.52% | -43.23% | |
| Return on Assets (ROA) | -59.67% | -53.66% | -39.03% | -30.51% | -26.92% | -26.15% | |
| Return on Capital (ROIC) | -75.69% | -70.38% | -45.36% | -32.94% | -28.73% | -27.65% | |
| Earnings Yield | -5.39% | -166.13% | -34.34% | -22.52% | -9.00% | -2.44% | |
| FCF Yield | -4.95% | -155.38% | -23.61% | -18.11% | -6.65% | -1.74% | |
| Buyback Yield / Dilution | -23.15% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
| Total Shareholder Return | -23.15% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.